# K260140: Aevice Wheeze Detection Module

- Pathway: 510(k) (Traditional)
- Applicant: Aevice Health Pte., Ltd.
- Decided: Sep 25, 2026 after 248 days
- Product code: PHZ (Abnormal Breath Sound Device)
- Device class: 2
- Regulation: 21 CFR 868.1900
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K980878 (1998). 8 ancestors in all.
No later device cites it as a predicate yet.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K232237: Tyto Insights for Wheeze Detection, Tyto Care, Ltd. (2023) Summary page 5.

## Indications for use
The Aevice Wheeze Detection module is a decision support software system used in evaluation of lung sounds in adults and pediatrics (2 years and older). It analyzes the acoustic signal of the lung such as lung sound recorded by FDA cleared compatible electronic stethoscope, such as AeviceMD, and identifies recordings where a specific abnormal lung sound suggestive of “Wheeze” is suspected. It is not intended to detect other abnormal or normal lung sounds. A licensed health care professional’s advice is required to understand the meaning of the Aevice Wheeze Detection result. Healthcare providers should consider the device result in conjunction with recording and other relevant patient data.

Source page: https://510kreport.com/device/K260140
Methodology: https://510kreport.com/methodology